Jaishankar Briefs MEA Consultative Committee, Panel Lauds India’s Vaccine Feat

Sources said one of the members raised the issue of delay in WHO’s approval for Bharat Biotech’s Covaxin, to which Jaishankar is said to have replied that the WHO’s decision could not second guessed.

Source: Top India News- News18.com